DiaPlexQ™ Novel Coronavirus (2019-nCoV) Detection Kit

Real-Time OneStep RT-PCR based assay system for detection of 2019-nCoV

[Product Certificate]

KFDA-EUA, U.S FDA EUA, Health Canada EUA, CE-IVD

The DiaPlexQ™ Novel Coronavirus (2019-nCoV) Detection Kit is a real-time reverse transcriptase (RT)-PCR test intended for the qualitative detection of nucleic acid from SARS-CoV-2 in nasopharyngeal swabs, oropharyngeal (throat) swabs, anterior nasal swabs, mid-turbinate nasal swabs, nasal aspirates, nasal washes, bronchoalveolar lavage (BAL) fluid and sputum from individuals suspected of COVID-19 by their healthcare provider.

Results are for the identification of SARS-CoV-2 RNA. The SARS-CoV-2 RNA is generally detectable in respiratory specimens during the acute phase of infection. Positive results are indicative of the presence of SARS-CoV-2 RNA; clinical correlation with patient history and other diagnostic information is necessary to determine patient infection status. The agent detected may not be the definite cause of disease. Positive results do not rule out bacterial infection or co-infection with other viruses.

Negative results do not preclude SARS-CoV-2 infection and should not be used as the sole basis for patient management decisions. Negative results must be combined with clinical observations, patient history, and epidemiological information.

The DiaPlexQ™ Novel Coronavirus (2019-nCoV) Detection Kit is intended for use by qualified clinical laboratory personnel specifically instructed and trained in the techniques of real-time PCR and in vitro diagnostic procedures.

Contents

Specification

Features

- Simple & Rapid detection system: OneStep Multiplex RT-qPCR based detection

- HotStart PCR: high-specificity

- Reliable system: automatic PCR control (not Internal control)

- Easy-to-use master mix: just adding template and Primer/Probe Mix

- Positive control included (Plasmid)

Experimental

Example

Ordering information